Literature DB >> 18218778

Anoikis effector Bit1 negatively regulates Erk activity.

Rania Kairouz-Wahbe1, Hector Biliran, Xiuquan Luo, Ingwei Khor, Miriam Wankell, Cynthia Besch-Williford, Jaime Pascual, Robert Oshima, Erkki Ruoslahti.   

Abstract

Bcl-2 inhibitor of transcription (Bit1) is a mitochondrial protein that functions as a peptidyl-tRNA hydrolase, but, when released into the cytoplasm, it elicits apoptosis. The proapoptotic function is uniquely counteracted by integrin-mediated cell attachment. We generated a conditional KO mouse of the Bit1 gene by using the Cre-LoxP recombination system. Bit1-null mice were born alive but with some developmental abnormalities. They developed a runting syndrome after birth and died within the first 2 weeks. Cultured fibroblasts from the Bit1-null embryos [mouse embryo fibroblasts (MEFs)] were more resistant to cell death induced by loss of attachment to extracellular matrix (anoikis) than cells from the wild-type or heterozygous littermates. MEFs and tissues from Bit1 KO mice displayed a marked increase in Erk phosphorylation. Knocking down Bit1 expression in cultured cells resulted in increased Erk activation, and partially knocking down Erk reversed the increased anoikis resistance of Bit1 knockdown. The enhanced Erk activation was associated with decreased Erk phosphatase activity. These studies establish the physiological significance of Bit1 activity and begin to delineate a Bit1 signaling pathway that acts through Erk regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218778      PMCID: PMC2234178          DOI: 10.1073/pnas.0711357105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Groucho/TLE family proteins and transcriptional repression.

Authors:  G Chen; A J Courey
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

2.  The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.

Authors:  S M Pettiford; R Herbst
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

3.  Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway.

Authors:  A Glading; P Chang; D A Lauffenburger; A Wells
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  Orthologs of a novel archaeal and of the bacterial peptidyl-tRNA hydrolase are nonessential in yeast.

Authors:  Guillermina Rosas-Sandoval; Alexandre Ambrogelly; Jesse Rinehart; David Wei; L Rogelio Cruz-Vera; David E Graham; Karl O Stetter; Gabriel Guarneros; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

5.  Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics.

Authors:  C H Lai; C Y Chou; L Y Ch'ang; C S Liu; W Lin
Journal:  Genome Res       Date:  2000-05       Impact factor: 9.043

6.  Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt.

Authors:  O Zugasti; W Rul; P Roux; C Peyssonnaux; A Eychene; T F Franke; P Fort; U Hibner
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  Adhesion regulation of stromal cell-derived factor-1 activation of ERK in lymphocytes by phosphatases.

Authors:  Tonya Laakko; Rudolph L Juliano
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

8.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.

Authors:  Emmanuel Vial; Erik Sahai; Christopher J Marshall
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

Review 9.  Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

Authors:  S M Keyse
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

10.  Involvement of phosphatases in the anchorage-dependent regulation of ERK2 activation.

Authors:  Masaru Mitsushima; Kazumitsu Ueda; Noriyuki Kioka
Journal:  Exp Cell Res       Date:  2007-03-12       Impact factor: 3.905

View more
  22 in total

1.  Bit1-a novel regulator of astrocyte function during retinal development: proliferation, migration, and paracrine effects on vascular endothelial cell.

Authors:  Yan Liu; Jiali Ji; Wanyu Shao; Min Luo; Bo Ma
Journal:  Hum Cell       Date:  2019-07-31       Impact factor: 4.174

2.  CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.

Authors:  X Hu; Y Zhao; L Wei; B Zhu; D Song; J Wang; L Yu; J Wu
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

3.  Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.

Authors:  Xin Yao; Selena Gray; Tri Pham; Mychael Delgardo; An Nguyen; Stephen Do; Shubha Kale Ireland; Renwei Chen; Asim B Abdel-Mageed; Hector Biliran
Journal:  Biochem Biophys Res Commun       Date:  2017-11-21       Impact factor: 3.575

4.  Bit1-a potential positive regulator of epithelial-mesenchymal transition in lens epithelial cells.

Authors:  Xinhua Wu; Jing Ruan; Bo Ma; Min Luo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-28       Impact factor: 3.117

5.  Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma.

Authors:  Tianli Fan; Fang Tian; Shanyong Yi; Yang Ke; Shengna Han; Lirong Zhang; Hongtao Liu
Journal:  Tumour Biol       Date:  2013-08-17

6.  Application of a proapoptotic peptide to intratumorally spreading cancer therapy.

Authors:  Renwei Chen; Gary B Braun; Xiuquan Luo; Kazuki N Sugahara; Tambet Teesalu; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2012-12-17       Impact factor: 12.701

Review 7.  Bit1 in anoikis resistance and tumor metastasis.

Authors:  Scott Jenning; Tri Pham; Shubha Kale Ireland; Erkki Ruoslahti; Hector Biliran
Journal:  Cancer Lett       Date:  2013-01-31       Impact factor: 8.679

8.  Protein kinase D is a positive regulator of Bit1 apoptotic function.

Authors:  Hector Biliran; Yiwen Jan; Renwei Chen; Elena B Pasquale; Erkki Ruoslahti
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

9.  Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder.

Authors:  Pauline E Schneeberger; Fanny Kortüm; Georg Christoph Korenke; Malik Alawi; René Santer; Mathias Woidy; Daniela Buhas; Stephanie Fox; Jane Juusola; Majid Alfadhel; Bryn D Webb; Emanuele G Coci; Rami Abou Jamra; Manuela Siekmeyer; Saskia Biskup; Corina Heller; Esther M Maier; Poupak Javaher-Haghighi; Maria F Bedeschi; Paola F Ajmone; Maria Iascone; Hilde Peeters; Katleen Ballon; Jaak Jaeken; Aroa Rodríguez Alonso; María Palomares-Bralo; Fernando Santos-Simarro; Marije E C Meuwissen; Diane Beysen; R Frank Kooy; Henry Houlden; David Murphy; Mohammad Doosti; Ehsan G Karimiani; Majid Mojarrad; Reza Maroofian; Lenka Noskova; Stanislav Kmoch; Tomas Honzik; Heidi Cope; Amarilis Sanchez-Valle; Bruce D Gelb; Ingo Kurth; Maja Hempel; Kerstin Kutsche
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

Review 10.  Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis.

Authors:  Kevin Tan; David Goldstein; Philip Crowe; Jia-Lin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-04       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.